InvestorService: Genmab, to Present at 2007 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

February 05, 2007 02:13 ET | Source: Genmab A/S Genmab A/S

Genmab's CEO will present at the 2007 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City on February 7.

Attachments

102611.pdf...

Recommended Reading

December 29, 2025 08:10 ET | Source: Genmab A/S

Genmab Portfolio Prioritization Update

Company Announcement Genmab to discontinue clinical development of acasunlimab following a portfolio reviewDecision reflects prioritization of higher‑impact opportunities across Genmab’s late‑stage...
Read More
December 12, 2025 01:35 ET | Source: Genmab A/S

Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period

Company Announcement Transaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolioTransaction anticipated to be accretive to Genmab’s EBITDA by...
Read More